Suppr超能文献

2019年至2021年德国急性中风护理的演变:对全国行政数据集的分析。

The evolution of acute stroke care in Germany from 2019 to 2021: analysis of nation-wide administrative datasets.

作者信息

Ungerer Matthias N, Bartig Dirk, Richter Daniel, Krogias Christos, Hacke Werner, Gumbinger Christoph

机构信息

Department of Neurology, University Hospital Heidelberg, Heidelberg, Germany.

DRG Market, Osnabrück, Germany.

出版信息

Neurol Res Pract. 2024 Jan 11;6(1):4. doi: 10.1186/s42466-023-00297-x.

Abstract

BACKGROUND

The treatment of ischemic stroke (IS) has changed considerably in recent years. Particularly the advent of mechanical thrombectomy (MTE) has revolutionized the available treatment options. Most patients in developed countries have access to intravenous thrombolysis (IVT). However access to MTE remains restricted in some regions despite efforts to increase its availability. We performed an evaluation of national datasets to monitor improvements made in access to revascularization therapies for IS patients in Germany.

METHODS

We analyzed national datasets on German Diagnosis-Related Groups and structured quality reports by extracting information of patients admitted with stroke with and without IVT and MTE for the period of 2019-2021. Data from 2016 and limited data for 2022 were also included for comparison.

RESULTS

Admissions with ischemic stroke declined during the years of the COVID 19 pandemic by 4.5% from 227,258 in 2019 to 216,923 in 2021. IVT rates were stable with 16.3% being treated with IVT in 2019 and 2021. MTE rates continued to increase from 7.1 to 8.4% and the number of MTE centers increased by 14.8% in the same period. Over 87.3% of MTEs were performed in centers with a case volume exceeding 50 cases per year in 2021. The largest increase in the relative share of MTEs was seen in large MTE centers (n ≥ 200). Patient age for MTEs surpassed the age for IVTs in 2019 and the proportion of patients ≥ 80 years receiving MTE continued to increase. The proportion of regions in Germany with poor MTE rates (≤ 4.1%) decreased significantly from 2019 (12.3%) to 2021 (5.3%) (p < 0.001).

CONCLUSIONS

We found strong evidence that while IVT rates reached a temporary ceiling effect, both the absolute number of and access to MTEs continued to increase in Germany. Regional disparities have become less significant and the majority of MTEs are performed in centers with medium or high case volumes.

摘要

背景

近年来,缺血性中风(IS)的治疗发生了很大变化。特别是机械取栓术(MTE)的出现彻底改变了现有的治疗选择。发达国家的大多数患者都能接受静脉溶栓治疗(IVT)。然而,尽管一直在努力提高其可及性,但在某些地区,MTE的可及性仍然受限。我们对国家数据集进行了评估,以监测德国IS患者接受血管再通治疗的可及性改善情况。

方法

我们通过提取2019 - 2021年期间接受或未接受IVT和MTE治疗的中风患者信息,分析了德国诊断相关组的国家数据集和结构化质量报告。还纳入了2016年的数据以及2022年的有限数据进行比较。

结果

在新冠疫情期间,缺血性中风的入院人数下降了4.5%,从2019年的227,258例降至2021年的216,923例。IVT率保持稳定,2019年和2021年接受IVT治疗的比例均为16.3%。MTE率从7.1%持续上升至8.4%,同期MTE中心的数量增加了14.8%。2021年,超过87.3%的MTE手术在每年病例量超过50例的中心进行。MTE相对份额增长最大的是大型MTE中心(n≥200)。2019年,接受MTE治疗的患者年龄超过了接受IVT治疗的患者年龄,且80岁及以上接受MTE治疗的患者比例持续上升。德国MTE率较低(≤4.1%)的地区比例从2019年的12.3%显著下降至2021年的5.3%(p<0.001)。

结论

我们发现有力证据表明,虽然IVT率达到了暂时的上限效应,但在德国,MTE的绝对数量和可及性都在持续增加。地区差异变得不那么显著,大多数MTE手术在病例量中等或较高的中心进行。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8ff/10782681/1e7e0c483186/42466_2023_297_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验